Real-time enrollment status for this castration-resistant prostate cancer (crpc) clinical trial
Current Status
Recruiting
Checked: September 18, 2026 at 11:30 PM UTC
| NCT Number | NCT07745361 |
| Recruiting Status | Recruiting |
| Condition | Castration-Resistant Prostate Cancer (CRPC) |
| Phase | PHASE2 |
| Target Enrollment | 25 participants |
| Active Locations | 14 sites in the US |
| Sponsor | Monte Rosa Therapeutics, Inc |
| Last Updated on CT.gov | August 24, 2026 (3 weeks ago) |
As of September 18, 2026: Clinical trial NCT07745361 is currently recruiting participants. This phase2 study for castration-resistant prostate cancer (crpc) is actively seeking new participants at 14 locations across the United States. The study is sponsored by Monte Rosa Therapeutics, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07745361 is actively recruiting participants as of September 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07745361 was last updated 3 weeks ago (August 24, 2026). HelloStudys verifies this status automatically.